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Background and Aims: Dietary gangliosides are present in human milk and consumed
in low amounts from organ meats. Clinical and animal studies indicate that dietary
gangliosides attenuate signaling processes that are a hallmark of inflammatory bowel
disease (IBD). Gangliosides decrease pro-inflammatory markers, improve intestinal
permeability, and reduce symptoms characteristic in patients with IBD. The objective
of this study was to examine mechanisms by which dietary gangliosides exert beneficial
effects on intestinal health.
Methods: Studies were conducted in vitro using CaCo-2 intestinal epithelial cells.
Gangliosides were extracted from milk powder and incubated with differentiated
CaCo-2 cells after exposure to pro-inflammatory stimuli. Gut barrier integrity was
assessed by electron microscopy, epithelial barrier function was examined by measuring
transepithelial electric resistance, and content of HBD-2, IL-23, NF-κB, and sPLA2 was
assessed by ELISA.
Results: Ganglioside attenuated the decrease in integrity of tight junctions induced by
pro-inflammatory stimuli and improved epithelial barrier function (P < 0.05). Ganglioside
decreased the basolateral secretion of sPLA2 (P≤ 0.05), lowered HBD-2 and IL-23 levels
(P ≤ 0.05), and inhibited NF-κB activation (P ≤ 0.05).
Conclusions: In summary, the present study indicates that ganglioside GD3 improves
intestinal integrity by altering sPLA2 trafficking, and the production of pro-inflammatory
mediators is mitigated by decreasing assembly of the NF-κB complex. Dietary
gangliosides may have promising potential beneficial effects in IBD as decreased
inflammatory signaling, improved intestinal integrity, and maintenance of epithelial barrier
function have been demonstrated in vitro.
Keywords: crohn, nutrition, ulcerative colitis, sphingolipid, immunology, inflammatory bowel disease,
inflammation, intestinal permeability
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INTRODUCTION
Inflammatory bowel disease (IBD) is a chronic, relapsing
disorder resulting from persistent inflammation affecting the
mucosa of the gastrointestinal tract (1). Management of Crohn
disease (CD) and ulcerative colitis (UC) is challenging and
may consist of drug treatments including glucocorticosteroids,
immunosuppressants, and/or biologics. Some individuals with
IBD do not respond to drug treatment, while others experience
adverse effects associated with treatment (2). Failure to maintain
remission is common, thus new treatment initiatives are
urgently needed.
Individuals consuming diet abundant in anti-inflammatory
bioactives have a reduced risk for CD (3). Gangliosides are
a class of polar lipids abundantly expressed in the nervous
system and found ubiquitously in tissues and body fluids,
including human milk (4). Ingestion of dietary ganglioside was
shown to be safe at 43 mg/day for 8 weeks in adults (5). The
bioavailability of ganglioside has been demonstrated as plasma
concentration of ganglioside GD3 increased 40% within 2 weeks
of supplementation with ganglioside in healthy adults and in
adults with IBD (5). Dietary gangliosides consumed from a
complex milk-lipid fraction reduced intestinal permeability by
19% in healthy adults, and also improved emotional health and
systemic symptoms in a pilot study of five participants with
IBD without a placebo control after 8 weeks of consumption
(5). Dietary ganglioside is safe for consumption and has
demonstrated clinical benefit in patients with IBD.
Reduction of ganglioside content is a hallmark of intestinal
inflammation (2). The content of ganglioside catabolic enzymes
beta-hexosaminidase and sialidase are elevated in the intestinal
mucosa of patients with IBD relative to a control group (6),
suggesting a depletion of ganglioside GD3 species in CD
and UC. Exposure of infant bowel to ganglioside ex vivo
reduced bowel necrosis and endothelin-1 production in response
to lipopolysaccharide (LPS) (7). Dietary gangliosides increase
cellular ganglioside content and decrease cholesterol content
of microdomains in a rodent model (8). Reduced content of
cholesterol in enterocyte membranes inhibits cellular entry of
pathogens (9) and decreases the generation of pro-inflammatory
signals (8). The mechanisms underlying the mitigation of
pro-inflammatory signaling by dietary gangliosides remains
largely unknown.
Intestinal epithelial cells are a key component to the
physiologic barrier between the myriad of toxins, microbes, and
antigens present in the gut lumen and the underlying mucosal
immune system (10). Defects in the intestinal barrier and
impaired immune function are characteristic of IBD. Disruption
of intestinal barrier function results in increased permeability
of the host gut to luminal antigens and bacteria, leading to
the immune response and inflammation (11). Para-cellular
permeability is regulated by a complex of macromolecules
commonly described as adherens or tight junctions. IL-
1β induces the expression of miR-200c-3p which causes a
downregulation of the tight junction protein occludin (12).
Dietary ganglioside has been reported to inhibit degradation
of occludin in a preclinical model of IBD (13). Secretory
phospholipase A2 (sPLA2) is a ubiquitous group of enzymes
implicated in turnover of membrane phospholipids and lipid
digestion. Activated sPLA2 catalyzes release of fatty acids
from the sn-2 position of phospholipid in membranes, which
is the first step in production of eicosanoids and other
inflammatory mediators (14) that result in degradation of tight
junction proteins.
Human beta-defensin (HBD)-2 coordinates innate and
acquired immune responses (15) through nuclear factor-κB
(NF-κB) (16). NF-κB is a primary regulator of inflammatory
responses and plays a critical role in a variety of physiological and
pathologic processes. Activation of NF-κB stimulates production
of interleukin-23 (IL-23) (17). After binding to the IL-23 receptor,
the production tumor necrosis factor alpha (TNF-α) is stimulated
from T-cells thus contributing to the pathogenesis of IBD (18).
It is crucial that efficacious therapies reduce TNF-α to induce
clinical, endoscopic, and histopathological healing (19).
The focus of this study was to determine the potential
mechanism by which ganglioside protects barrier integrity and
function in a model of intestinal cell inflammation. It is
hypothesized that ganglioside GD3 sustains barrier activity by
decreasing secretion of sPLA2, inhibiting NF-κB activation, and
mediating pro-inflammatory signaling.
METHODS
All authors had access to the study data and had reviewed and
approved the final manuscript.
Cell Culture
The human colon adenocarcinoma epithelial cell line CaCo-2
(American Type Culture Collection R© HTB-37TM) was grown
in complete medium (EMEM, Invitrogen), 10% (v/v) FBS, 1%
(v/v) antibiotic/antimycotic, 26mM sodium bicarbonate, 10mM
HEPES, 1mM pyruvic acid, (37◦C, 5% CO2). Cells were passaged
at 90% confluence using 0.25% trypsin-2.65mM EDTA and
subcultured at a density of 1.6 × 104 cells/cm2. All studies were
performed on confluent cells of the CaCo-2 subclone between
passages 20 and 40.
Preparation of Ganglioside
Gangliosides were extracted from Zeta lipid-2 milk powder
(Fonterra, Cambridge, New Zealand). Powder was added (1:60
w/v) to chloroform/methanol (C/M) (2:1 v/v), vortexed, and
shaken (>2 h). Tubes were inversed several times after adding
0.025% (w/v) CaCl2/H2O. After centrifugation, the upper layer
was withdrawn and applied to a Sep-Pak Classic C18 cartridge
(Waters). Cartridges were rinsed with H2O before eluting
ganglioside with methanol, followed by C/M (2:1 v/v). For
quantification, aliquots (duplicate) were dried under N2 gas
before H2O addition and vortex. Resorcinol-HCl was added to
tubes before vortex and heating (160◦C; 8min). After cooling to
room temperature, butylacetate/butanol (85:15 v/v) was added
to tubes and vortexed. The upper layer was withdrawn and
optical density was determined on a spectrophotometer (8452A,
Hewlett Packard) at 580 nm. Total ganglioside was quantified
as ganglioside-bound N-acetyl neuraminic acid with an N-
acetyl neuraminic acid standard (SigmaAldrich). Gangliosides
were dissolved in media (10µg/ml) and all media were
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FIGURE 1 | Ganglioside mitigates the disruption of junction complexes in CaCo-2 cells. Cell monolayers were exposed to pro-inflammatory stimulus with or without
ganglioside pre-incubation. There was disruption of the tight junctions, adherens junction, and desmosomes in DSS-treated cells (B) compared with control cells (A)
or cells pre-incubated with ganglioside (C). Arrows indicate tight junction, adherens junction and desmosomes. Images were obtained at 2600x magnification on a
Hitachi H7000 Transmission Electron Microscope.
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sonicated (130W, 30 sec) prior to filter sterilization through
a 0.2µm syringe filter to facilitate dissolution of potential
micelle formation.
Stimulation of Cells
CaCo-2 cells were cultured at a density of 2.5 × 107 cells/ml
on 0.4µm pore inserts in transwell plates (Corning Costar). The
apical (upper) and basolateral (lower) compartments contained
0.5 and 2ml of medium, respectively. After becoming confluent,
cultures were then grown for 3 weeks to facilitate differentiation
and expression of villi, microvilli, and small intestinal enterocyte
function (20). Cells were divided into groups with the following
experimental conditions for 48 h: grown in complete medium
(control), incubated with ganglioside (10µg/ml), exposure to
LPS (100µg/ml), or exposure to DSS (2.5%; Sigma Aldrich).
Ganglioside was added to the culture medium 19 days after
cultures became confluent. The cells were incubated for 24 h with
LPS or for 48 h with DSS from the apical side 21 days after
cultures became confluent. Culture media were collected and
analyzed for HBD-2, IL-23, and sPLA2; and cells were harvested
for analysis of NF-κB.
Electron Microscopy
CaCo-2 cell monolayers were incubated in 2.5% (w/v) of
glutaraldehyde/cacodylate buffer (pH 7.2) for 1.5 h and
subsequently washed in this same buffer three times for 15min
before being fixed in 1% (v/v) osmium tetroxide buffer for 1.5 h
at room temperature. Cells were then rinsed in distilled water;
dehydrated in a series of 50, 70, and 90% absolute ethanol for
10min. Samples were then embedded in Spurr’s resin mixture
(Spurr’s resin/ethanol 50:50). Following polymerization at 70◦C
for 12 h, ultrathin sections were cut, stained with uranyl acetate
and lead citrate, and viewed with a Hitachi H7000 Transmission
Electron Microscope (Tokyo, Japan), or with a Hitachi Scanning
Electron Microscope S2500 (Tokyo, Japan) using a method
previously described (21) to examine the integrity of monolayers.
FIGURE 2 | Ganglioside mitigates the reduction in TEER induced by pro-inflammatory stimuli. TEER was measured at (A) 8 h and (B) 24 h, and in a (C) 48 h
timecourse after exposure to pro-inflammatory stimuli (N = 6 biological replicates in cell culture wells per group; N = 3 technical instrument reader replicates). For (C),
TEER measurement was 237 ± 5 /cm2 at time = 0 h. Values illustrated the mean ± SD. Asterisks denotes statistical significance at *p < 0.05, **p < 0.01. In panel
(C), “DSS” significantly differs (p < 0.05) from “DSS + GG” at all-time points after 0 h. GG, ganglioside.
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TEER Assessment
Transepithelial electrical resistance (TEER) was assessed as
an index of confluence, integrity and barrier function of
cell monolayers (22). TEER of CaCo-2 monolayers grown
on collagen-coated filter inserts was measured using a Volt
Meter (World Precision Instruments, Hamden, CT). The
TEER value measured in the absence of cells was used as
background. The TEER of monolayers without added DSS
or ganglioside represented the controls for each experiment.
The TEER was measured in cell culture medium within one
min of removing from incubator (37◦C) before addition
of pro-inflammatory stimulus (time zero) and then at time
intervals and expressed as the ratio of the TEER at time
t to the initial value (at time zero) for each series. Time
course measurements were obtained independently from
unique transwells.
Measurement of Pro-inflammatory
Markers and Immune Mediators
NF-κB activation was assessed using a TransAM NF-κB
transcription factor family assay kit (Active Motif, Carlsbad,
CA) according to the manufacturer’s instructions. Human
IL-23, HBD-2, and sPLA2 were assayed from cell supernatants
using titerzyme ELISA Kits, according to the manufacturer’s
instructions (R&D Systems, Minneapolis, MN; Phoenix
Pharmaceuticals Inc.; Cayman Chemicals, MI). A microplate
reader (Eppendorf BioPhotometer) was used to determine optical
density at 450 nm and corrected for background at 540 nm.
Statistical Analysis
The study data may be made available to other researchers upon
request. All experiments were independently replicated at least
three times at different cell passages. Data are presented as mean
FIGURE 3 | Secretory PLA2 activity was decreased by ganglioside at the basolateral membrane. CaCo-2 cells were grown on transwell inserts and incubated with
ganglioside (10µg/ml) for 48 h prior to exposure with inflammatory stimuli. (A,C) Illustrate the content of sPLA2 in apical medium and (B,D) illustrate the content of
sPLA2 in basolateral medium (N = 8 biological replicates in cell culture wells per group; N = 3 technical instrument reader replicates). The mean ± SD is illustrated.
Asterisks denote statistical significance at *p < 0.05, **p < 0.01, ***p < 0.001. GG, ganglioside.
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FIGURE 4 | The content of HBD-2 and IL-23 is decreased by ganglioside. CaCo-2 cells grown on transwell inserts were incubated with ganglioside (10µg/ml) for 48
h prior to exposure with LPS (A,B) or DSS (C,D). Apical media were collected and analytes measured by ELISA (N = 8 biological replicates in cell culture wells per
group; N = 3 technical instrument reader replicates). Bars represent the mean ± SD. Asterisks denote statistical significance at *p < 0.05, **p < 0.01, ***p < 0.005.
GG, ganglioside.
± SD. Statistical testing was conducted using an ANOVA or
Duncan’s multiple range test. There was no interaction between
LPS and ganglioside when analyzed by a two-way ANOVA. An α
value below 0.05 was considered statistically significant.
RESULTS
Ganglioside Protected Intestinal Tight
Junction and Adhesion Junction Proteins
Visualization of CaCo-2 cell monolayer by electron microscopy
revealed intact tight junctions, adherens junctions, and
desmosomes in control cells (Figure 1A). DSS induced the
opening and disruption of tight junctions and desmosomes
(Figure 1B) which was attenuated by ganglioside (Figure 1C).
Pre-incubation with ganglioside prevented the decrease in TEER
induced by LPS and DSS (Figure 2).
Ganglioside Regulates Phospholipase
Activity
The concentration of sPLA2 was elevated after incubation
with LPS and ganglioside (Figures 3A,B). Pre-incubation with
gangliosidemitigated the DSS-induced trafficking of sPLA2 to the
basolateral membrane (Figures 3C,D).
Ganglioside Decreased Pro-inflammatory
Cytokine Levels
LPS stimulation increased HBD-2 and IL-23 in the apical
media from differentiated CaCo-2 cell monolayers (Figure 4).
Incubation with ganglioside alone did not affect HBD-
2 concentration compared to control. Pre-incubation with
ganglioside mitigated the increases in HBD-2 and IL-23
content induced by pro-inflammatory stimulus (Figure 4).
Incubation with pro-inflammatory stimuli significantly increased
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FIGURE 5 | Ganglioside inhibits LPS-stimulated activation of NF-κB P65 and
P52 subunits. CaCo-2 cells were incubated with ganglioside (10µg/ml) for
(Continued)
FIGURE 5 | 48 h prior to exposure with inflammatory stimuli. Gangliosides
mitigates the LPS-induced increase in subunits P65 (A) and P52 (B) but not
P50 (C), indicating that NF-κB complex formation and translocation is inhibited
by ganglioside. Values illustrated are means ± SD. (N = 6 biological replicates
in cell culture wells per group; N = 3 technical instrument reader replicates).
The asterisk denotes statistical significance at *p < 0.05, **p < 0.01. GG,
ganglioside.
NF-κB activation in CaCo-2 cells (Figure 5). Pre-incubation
with ganglioside reduced LPS-mediated activation of NF-
κB P65 and P52 subunits (Figures 5A,B), but not P60
subunit (Figure 5C).
DISCUSSION
The present study demonstrated that the disruption of intestinal
tight junction and adhesion junction and increase in intestinal
permeability induced by pro-inflammatory stimuli could be
mitigated by milk fat gangliosides consisting primarily of GD3
(Figure 6). This observation is consistent with findings in
preclinical research models where dietary ganglioside inhibited
degradation of tight junction protein occludin during LPS-
induced acute inflammation in rats (13). Furthermore, bovine
milk derived ganglioside mixture used in these experiments is
similar to the composition of gangliosides present in human
colostrum (23), predominantly GD3 (80%) with smaller amounts
(20%) of GM3, GM1, and GD1a.
Secretory PLA2 activity results in a reduction in barrier
integrity in CaCo-2 cells (24). Clinical research has shown
sPLA2 to be increased in serum and colonic mucosa of
patients with CD and UC (21). The present study suggests
that LPS upregulates the concentration of sPLA2 and that DSS
promotes trafficking of sPLA2 to the basolateral membrane
(Figure 6). However, ganglioside GD3 promoted trafficking
of sPLA2 to the apical membrane (Figure 6). Secretory
PLA2 enzymes catalyze hydrolysis of the sn-2 position of
membrane glycerophospholipids, leading to production of
free fatty acids, mainly polyunsaturated fatty acids, and
lysophospholipids. This reaction is of particular importance
and depends on the fatty acid present in the sn-2 position. A
long chain omega-3 fatty acid liberated at this position may
be converted to pro-resolving mediators, but arachidonic acid
may be converted to prostacyclin and bioactive eicosanoids
including prostaglandins and leukotrienes. Dietary ganglioside
downregulates production of pro-inflammatory mediators PGE2
and LTB4 in rats (25). Further research is needed to clarify
how ganglioside regulates trafficking and secretion of sPLA2 at
the apical and basolateral membranes and how the production
of pro-inflammatory or pro-resolving lipid-derived mediators
are affected.
Although enterocytes are targets of pathologic inflammation,
enterocytes are also actively involved in immune tolerance (26)
and generating an immune response at the mucosal level (27).
Elevated levels of pro-inflammatory cytokines are observed in
patients with IBD (28). HBD-2 and HBD-3 represent a link
between innate and adaptive immune responses and are induced
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FIGURE 6 | Mode of action of ganglioside. Pro-inflammatory stimuli upregulate sPLA2 trafficking, HBD-2 production, NF-κB subunit production and assembly, IL23
signaling, and tight junction degradation (A). Ganglioside protects mucosal integrity by (1) inhibiting secretion of HBD-2, (2) decreasing NF-κB assembly, (3) lowering
IL-23 production, and by (4) inhibiting trafficking of sPLA2 to the basolateral membrane (B). TJ. tight junction.
in intestinal dysbiosis (29) and during inflammation of CD and
UC (30, 31). In the present study, ganglioside GD3 prevented
the increase in IL-23 and secretion of HBD-2 induced by pro-
inflammatory stimuli (Figure 6). Probiotic strains of bacteria can
induce HBD-2 expression to function as a critical mediator of
T-regulatory cell induction (32) and immune tolerance (33, 34).
Taken together these data suggest that compromised immune
tolerance in IBD caused by NOD2 and ATG16L1 variants
(35) may be modulated by ganglioside to resolve mucosal
inflammation independent of the presence of risk alleles.
Genetic polymorphisms of the IL-23 receptor (IL-23R) are
frequently observed in IBD patients, signifying the importance
of IL-23 and IL-23R signaling in IBD pathogenesis (36).
Assembly of NF-κB facilitates IL-23 production (37) and the
coordinated recruitment of Th17 cells (38). NF-κB has been
identified as one of the key regulators in this immunological
setting and central to the function of monocytes that exacerbate
pro-inflammatory signaling. Macrophages and epithelial cells
isolated from inflamed gut specimens from IBD patients showed
augmented levels of NF-κB p65 (39). NF-κB subunits are kept
inactive in the cytoplasm by an endogenous inhibitor protein of
the IkB family (40). Under stimulation by IL-1 or LPS, IkB is
phosphorylated, selectively ubiquitinated and rapidly degraded
allowing NF-κB to translocate into the nucleus and induces
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target genes that have NF-κB binding domains (40). In IBD
patients, increased NF-κB expression in mucosal macrophages is
accompanied by increased capacity of these cells to produce and
secrete TNF-α, IL-1, and IL-6 (39). In the present study, exposure
of CaCo-2 cells to ganglioside GD3 mitigated the LPS-induced
activation of NF-κB by attenuating production of the P65 and P52
subunits (Figure 6).
The lack of use of an anti-inflammatory control may
be considered a limitation in this study. Whether the anti-
inflammatory mode of action of gangliosides is similar to that of
anti-inflammatory pharmaceuticals is unknow. In addition, only
a single dose of ganglioside was used in the in vitro experiments.
This was based on effective concentrations previously published
(9) in addition to choosing a dose below the critical micellar
concentration of gangliosides (41).
In summary, this study demonstrates that exposure of
CaCo-2 cells to inflammatory stimuli produced some of the
inflammatory responses characteristic of IBD. Exposure to
ganglioside GD3 mitigated production of pro-inflammatory
cytokines HBD-2 and IL-23 and this effect may be mediated
by lowering NF-κB activation (Figure 6). Ganglioside GD3
mitigates the disruption of tight junctions induced by pro-
inflammatory stimuli. Ganglioside protects intracellular
phospholipid integrity by mitigating sPLA2 production and
inhibiting sPLA2 trafficking to the basolateral membrane
of enterocytes. Ganglioside may have potential therapeutic
application either by inducing or maintaining remission in
IBD as this research study has demonstrated downregulation of
pro-inflammatory signaling in vitro.
DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included
in the article/supplementary material, further inquiries can be
directed to the corresponding authors.
AUTHOR CONTRIBUTIONS
JM (data curation: equal, resources: supporting,
visualization: equal, writing—review and editing: equal).
QL (conceptualization: supporting, formal analysis: lead,
investigation: lead, methodology: lead, visualization: equal,
writing—original draft: lead). JS (data curation: supporting,
visualization: equal). AT (supervision: supporting). VM
(supervision: supporting). MC (conceptualization: lead, funding
acquisition: lead, resources: lead, supervision: lead, writing—
review and editing: equal). All authors contributed to the article
and approved the submitted version.
FUNDING
Funding was provided primarily by the Canadian Institutes of
Health Research, award number 111077. Additional funding
from Chapman University was provided for publishing fees.
REFERENCES
1. Fretland DJ, Djuric SW, Gaginella TS. Eicosanoids and inflammatory
bowel disease: regulation and prospects for therapy. Prostaglandins
Leukot Essent Fatty Acids. (1990) 41:215–33. doi: 10.1016/0952-3278(90)
90135-8
2. Miklavcic JJ, Schnabl KL, Mazurak VC, Thomson AB, Clandinin MT. Dietary
Ganglioside reduces proinflammatory signaling in the intestine. J Nutr Metab.
(2012) 2012:280–6. doi: 10.1155/2012/280286
3. Lo CH, Lochhead P, Khalil H, Song M, Tabung FK, Burke KE, et al.
Dietary inflammatory potential and risk of Crohn’s disease and Ulcerative
Colitis. Gastroenterology. (2020) 159:873–3. doi: 10.1053/j.gastro.2020.
05.011
4. Yu RK, Nakatani Y, Yanagisawa M. The role of glycosphingolipid
metabolism in the developing brain. J Lipid Res. (2009) 50:S440–5.
doi: 10.1194/jlr.R800028-JLR200
5. Miklavcic JJ, Shoemaker GK, Schnabl KL, Larsen BM, Thomson AB,
Mazurak VC, et al. Ganglioside intake increases plasma ganglioside
content in human participants. J Parenter Enteral Nutr. (2017) 41:657–66.
doi: 10.1177/0148607115620093
6. Miklavcic JJ, Hart TD, Lees GM, Shoemaker GK, Schnabl KL, Larsen BM, et al.
Increased catabolism and decreased unsaturation of ganglioside in patients
with inflammatory bowel disease.World J Gastroenterol. (2015) 21:10080–90.
doi: 10.3748/wjg.v21.i35.10080
7. Schnabl KL, Larsen B, Van Aerde JE, Lees G, Evans M, Belosevic M, et al.
Gangliosides protect bowel in an infant model of necrotizing enterocolitis
by suppressing pro-inflammatory signals. J Pediatr Gastroenterol Nutr. (2009)
49:382–92. doi: 10.1097/MPG.0b013e3181b6456d
8. Park EJ, Suh M, Thomson B, Thomson AB, Ramanujam KS, Clandinin MT.
Dietary ganglioside decreases cholesterol content, caveolin expression and
inflammatory mediators in rat intestinal microdomains. Glycobiology. (2005)
15:935–42. doi: 10.1093/glycob/cwi078
9. Rivas-Serna IM, Mazurak VC, Keelan M, Clandinin MT. Modification of
ganglioside content of human gastric epithelial cell membrane decreases
Helicobacter pylori adhesion. J Pediatr Gastroenterol Nutr. (2017) 65:456–61.
doi: 10.1097/MPG.0000000000001612
10. DeWitt RC, Kudsk KA. The gut’s role in metabolism, mucosal barrier
function, and gut immunology. Infect Dis Clin North Am. (1999) 13:465–81.
doi: 10.1016/S0891-5520(05)70086-6
11. Kong J, Zhang Z, Musch MW. Novel role of the vitamin D receptor
in maintaining the integrity of the intestinal mucosal barrier. Am J
Physiol Gastrointest Liver Physiol. (2008) 294:G208–16. doi: 10.1152/ajpgi.003
98.2007
12. RawatM,NighotM, Al-Sadi R, Gupta Y, Viszwapriya D, YochumG, et al. IL1B
increases intestinal tight junction permeability by up-regulation of MIR200C-
3p, Which Degrades Occludin mRNA. Gastroenterology. (2020) 159:1375–89.
doi: 10.1053/j.gastro.2020.06.038
13. Park EJ, Thomson AB, Clandinin MT. Protection of intestinal occludin
tight junction protein by dietary gangliosides in lipopolysaccharide induced
acute inflammation. J Pediatr Gastroenterol Nutr. (2010) 50:321–28.
doi: 10.1097/MPG.0b013e3181ae2ba0
14. Dennis EA. The growing phospholipase A2 superfamily of
signal transduction enzymes. Trends Biochem Sci. (1997) 22:1–2.
doi: 10.1016/S0968-0004(96)20031-3
15. Oppenheim JJ, Biragyn A, Kwak LW, Yang D. Roles of antimicrobial peptides
such as defensins in innate and adaptive immunity. Ann Rheum Dis. (2003)
62:ii17–21. doi: 10.1136/ard.62.suppl_2.ii17
16. Barnes PJ, Karin M. Nuclear factor-κB—a pivotal transcription factor
in chronic inflammatory diseases. N Engl J Med. (1997) 336:1066–71.
doi: 10.1056/NEJM199704103361506
17. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. Novel
p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological
activities similar as well as distinct from IL-12. Immunity. (2000) 13:715–25.
doi: 10.1016/S1074-7613(00)00070-4
Frontiers in Nutrition | www.frontiersin.org 9 July 2021 | Volume 8 | Article 705172
Miklavcic et al. Ganglioside Protects Tight Junction Integrity
18. McGovern D, Powrie F. The IL23 axis plays a key role in the pathogenesis of
IBD. Gut. (2007) 56:1333–6. doi: 10.1136/gut.2006.115402
19. Yzet C, Diouf M, Le Mouel JP, Brazier F, Turpin J, Loreau J, et al. Complete
endoscopic healing associated with better outcomes than partial endoscopic
healing in patients with Crohn’s disease. Clin Gastroenterol Hepatol. (2020)
18:2256–61. doi: 10.1016/j.cgh.2019.11.025
20. Li Q, Thomson AB, Clandinin MT. Cholesterol ester and free fatty acids are
modulated by Policosanol in CaCo-2 intestinal cells. J Am Coll Nutr. (2011)
30:201–9. doi: 10.1080/07315724.2011.10719961
21. Minami T, Tojo H, Shinomura Y, Matsuzawa Y, Okamoto M. Increased group
II phospholipase A2 in colonic mucosa of patients with Crohn’s disease and
ulcerative colitis. Gut. (1994) 35:1593–8. doi: 10.1136/gut.35.11.1593
22. Huynh-Delerme C, Huet H, Noel L, Frigieri A, Kolf-Clauw M.
Increased functional expression of P-glycoprotein in Caco-2 TC7 cells
exposed long-term to cadmium. Toxicol In Vitro. (2005) 19:439–47.
doi: 10.1016/j.tiv.2004.08.003
23. Ma L, MacGibbon AKH, Jan Mohamed HJB, Loy S, Rowan A, McJarrow P,
et al. Determination of ganglioside concentrations in breast milk and serum
from Malaysian mothers using a high performance liquid chromatography-
mass spectrometry-multiple reaction monitoring method. Int Dairy J. (2015)
49:62–71. doi: 10.1016/j.idairyj.2015.05.006
24. Sawai T, Usui N, Dwaihy J, Drongowski RA, Abe A, Coran AG, et al. The effect
of phospholipase A2 on bacterial translocation in a cell culture model. Pediatr
Surg Int. (2000) 16:262–6. doi: 10.1007/s003830050741
25. Park EJ, Suh M, Thomson B, Ma DW, Ramanujam K, Thomson
AB, et al. Dietary ganglioside inhibits acute inflammatory signals
in intestinal mucosa and blood induced by systemic inflammation
of Escherichia coli lipopolysaccharide. Shock. (2007) 28:112–7.
doi: 10.1097/SHK.0b013e3180310fec
26. Cohen LJ, Cho JH, Gevers D, Chu H. Genetic factors and the
intestinal microbiome guide development of microbe-based therapies
for inflammatory bowel diseases. Gastroenterology. (2019) 156:2174–89.
doi: 10.1053/j.gastro.2019.03.017
27. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis.
Gastroenterology. (1998) 115:182–205. doi: 10.1016/S0016-5085(98)70381-6
28. Tazuke Y, Drongowski RA, Teitelbaum DH, Coran AG. Interleukin-6 changes
tight junction permeability and intracellular phospholipid content in a
human enterocyte cell culture model. Pediatr Surg Int. (2003) 19:321–5.
doi: 10.1007/s00383-003-1003-8
29. Meade KG, O’Farrelly C. beta-Defensins: farming the microbiome
for homeostasis and health. Front Immunol. (2018) 9:3072.
doi: 10.3389/fimmu.2018.03072
30. Wehkamp J, Harder J, Weichenthal M, Mueller O, Herrlinger KR, Fellermann
K, et al. Inducible and constitutive β- defensins are differentially expressed in
Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. (2003) 9:215–23.
doi: 10.1097/00054725-200307000-00001
31. Kiehne K, Brunke G, Wegner F, Banasiewicz T, Folsch UR, Herzig KH.
Defensin expression in chronic pouchitis in patients with ulcerative colitis or
familial adenomatous polyposis coli. World J Gastroenterol. (2006) 12:1056–
62. doi: 10.3748/wjg.v12.i7.1056
32. David R. Regulatory T cells: a helping hand from Bacteroides fragilis. Nat Rev
Immunol. (2010) 10:539. doi: 10.1038/nri2827
33. Wehkamp J, Harder J, Wehkamp K, Wehkamp-von Meissner B, Schlee
M, Enders C, et al. NF-κBand AP-1-mediated induction of human beta
defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a
novel effect of a probiotic bacterium. Infect Immun. (2004) 72:5750–8.
doi: 10.1128/IAI.72.10.5750-5758.2004
34. Schlee M, Harder J, Koten B, Stange EF, Wehkamp J, Fellermann K. Probiotic
lactobacilli and VSL# 3 induce enterocyte β- defensin 2. Clin Exp Immunol.
(2008) 151:528–35. doi: 10.1111/j.1365-2249.2007.03587.x
35. Chu H, Khosravi A, Kusumawardhani I, Kwon AHK, Vasconcelos
AC, Cunha LD, et al. Gene-microbiota interactions contribute to the
pathogenesis of inflammatory bowel disease. Science. (2016) 352:1116–20.
doi: 10.1126/science.aad9948
36. Kim DJ, Kim KS, Song MY, Seo SH, Kim SJ, Yang BG, et al. Delivery of
IL-12p40 ameliorates DSS-induced colitis by suppressing IL17A expression
and inflammation in the intestinal mucosa. Clin Immunol. (2012) 144:190–9.
doi: 10.1016/j.clim.2012.06.009
37. Cho ML, Kang JW, Moon YM, Nam HJ, Jhun JY, Heo SB, et al. STAT3
and NF-kappaB signal pathway is required for IL-23-mediated IL-17
production in spontaneous arthritis animal model IL-1 receptor antagonist-
deficient mice. J Immunol. (2006) 176:5652–61. doi: 10.4049/jimmunol.176.
9.5652
38. Liu Z, Yadav PK, Xu X, Su J, Chen C, Tang M, et al. The increased expression
of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina
propria lymphocyte inflammatory responses and cytotoxicity. J Leukoc Biol.
(2011) 89:597–606. doi: 10.1189/jlb.0810456
39. Neurath MF, Pettersson S, Meyer Zum Büschenfelde KH, Strober W. Local
administration of antisense phosphorothioate oligonucleotides to the p65
subunit of NF–κB abrogates established experimental colitis in mice.NatMed.
(1996) 2:998–1004. doi: 10.1038/nm0996-998
40. Liboni KC, Li N, Scumpia PO, Neu J. Glutamine modulates LPS-induced
IL-8 production through IkappaB/NF-kappaB in human fetal and adult
intestinal epithelium. J Nutr. (2005) 135:245–51. doi: 10.1093/jn/135.
2.245
41. Formisano S, Johnson ML, Lee G, Aloj SM, Edelhoch H. Critical
micelle concentrations of gangliosides. Biochemistry. (1979) 18:1119–24.
doi: 10.1021/bi00573a028
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2021 Miklavcic, Li, Skolnick, Thomson, Mazurak and Clandinin. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Nutrition | www.frontiersin.org 10 July 2021 | Volume 8 | Article 705172
